Literature DB >> 9222199

High-frequency stimulation of the globus pallidus for the treatment of Parkinson's disease.

R Pahwa1, S Wilkinson, D Smith, K Lyons, E Miyawaki, W C Koller.   

Abstract

Long-term treatment of Parkinson's disease (PD) with levodopa is complicated by the development of motor fluctuations and dyskinesias. Posteroventral pallidotomy can improve tremor, bradykinesia, rigidity, and dyskinesias in PD. We performed chronic stimulation of the globus pallidus (CSGP) to duplicate the positive results of pallidotomy with reduced risk of permanent neurologic deficit in patients with advanced PD. The lead for CSGP was stereotactically implanted with the aid of microelectrode recordings in the globus pallidus pars interna. An electrical pulse generator was implanted in the subclavicular region. Stimulation settings were adjusted by computer. Five PD patients (four men, one woman) with disabling symptoms were enrolled. Three of the patients had bilateral implants. At 3 months following the last implant, four patients rated themselves as markedly improved, and one patient was moderately improved. The amount of time in the "on" state increased from 21% at baseline to 65% at 3-month follow-up (p < 0.05). There was a significant improvement in all subscales of the UPDRS (p < 0.05). One patient had an asymptomatic intracranial bleed, one patient had transient hemiparesis during surgery with stimulation, and one patient required surgical repositioning of the lead. Adverse effects caused by stimulation were minimal. CSGP is a safe and effective procedure in PD patients with motor fluctuations and dyskinesias.

Entities:  

Mesh:

Year:  1997        PMID: 9222199     DOI: 10.1212/wnl.49.1.249

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  24 in total

1.  Acute and chronic effects of anteromedial globus pallidus stimulation in Parkinson's disease.

Authors:  F Durif; J J Lemaire; B Debilly; G Dordain
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-09       Impact factor: 10.154

2.  Parkinson's Disease: Motor Fluctuations.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  1999-03       Impact factor: 3.598

3.  MRI directed bilateral stimulation of the subthalamic nucleus in patients with Parkinson's disease.

Authors:  N K Patel; P Plaha; K O'Sullivan; R McCarter; P Heywood; S S Gill
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-12       Impact factor: 10.154

4.  Modulation of metabolic brain function by bilateral subthalamic nucleus stimulation in the treatment of Parkinson's disease.

Authors:  Jian Wang; YiLong Ma; ZheMin Huang; BoMin Sun; YiHui Guan; ChuanTao Zuo
Journal:  J Neurol       Date:  2009-08-07       Impact factor: 4.849

5.  Prosthetic systems for therapeutic optical activation and silencing of genetically-targeted neurons.

Authors:  Jacob G Bernstein; Xue Han; Michael A Henninger; Emily Y Ko; Xiaofeng Qian; Giovanni Talei Franzesi; Jackie P McConnell; Patrick Stern; Robert Desimone; Edward S Boyden
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2008

6.  Depth perception in cerebellar and basal ganglia disease.

Authors:  Matthias Maschke; Christopher M Gomez; Paul J Tuite; Kristen Pickett; Jürgen Konczak
Journal:  Exp Brain Res       Date:  2006-05-30       Impact factor: 1.972

Review 7.  Tremor-predominant Parkinson's disease. Approaches to treatment.

Authors:  J Marjama-Lyons; W Koller
Journal:  Drugs Aging       Date:  2000-04       Impact factor: 3.923

8.  Titania nanotube arrays as interfaces for neural prostheses.

Authors:  Jonathan A Sorkin; Stephen Hughes; Paulo Soares; Ketul C Popat
Journal:  Mater Sci Eng C Mater Biol Appl       Date:  2015-01-26       Impact factor: 7.328

Review 9.  Postural instability in patients with Parkinson's disease. Epidemiology, pathophysiology and management.

Authors:  Samuel D Kim; Natalie E Allen; Colleen G Canning; Victor S C Fung
Journal:  CNS Drugs       Date:  2013-02       Impact factor: 5.749

Review 10.  The treatment of movement disorders by deep brain stimulation.

Authors:  Hong Yu; Joseph S Neimat
Journal:  Neurotherapeutics       Date:  2008-01       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.